| CAS No.: | 141977-79-9 |
|---|---|
| Formula: | C181h291n55o51s 2 |
| Type: | Pharmaceutical Intermediates |
| Appearance: | Powder |
| Quality: | Technical |
| Colour: | White |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier Introduction:
Miriplatin is a novel chemotherapy drug designed specifically for the treatment of liver cancer. With its unique mechanism of action and remarkable efficacy, Miriplatin has shown great promise in improving patient outcomes.
Miriplatin exerts its therapeutic effects by selectively targeting and destroying cancer cells in the liver. It works by inhibiting the DNA synthesis process, thereby preventing cancer cells from dividing and multiplying. This targeted approach minimizes damage to surrounding healthy tissues and reduces the risk of adverse side effects.
Function:
One of the key advantages of Miriplatin is its excellent efficacy in treating liver cancer. Clinical studies have demonstrated that it can effectively shrink tumors, inhibit tumor growth, and improve overall survival rates in patients. Furthermore, Miriplatin has shown to be particularly effective in cases where traditional treatments, such as surgery or radiation therapy, are not feasible.
In addition to its primary use in treating liver cancer, Miriplatin has also shown potential in combination therapy with other anti-cancer agents. This approach aims to enhance the treatment response and overcome resistance to chemotherapy, further improving patient outcomes.
Application:
The use of Miriplatin is not without side effects; however, they are generally manageable. Common side effects include nausea, vomiting, fatigue, and temporary liver function abnormalities. Close monitoring and supportive care are important to ensure patient well-being during treatment.
1. Are you a manufacturer or trading company?
A: We are a manufacturer and welcome to visit our factory.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}